Which has higher earnings and valuation, CNXU or SNWV?

Sanuwave Health has higher revenue and earnings than Conexeu Sciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Conexeu Sciences N/A N/A N/A N/A N/A Sanuwave Health $44.05M 2.08 $11.81M $0.33 32.21

Does the media refer more to CNXU or SNWV?

In the previous week, Conexeu Sciences had 11 more articles in the media than Sanuwave Health. MarketBeat recorded 13 mentions for Conexeu Sciences and 2 mentions for Sanuwave Health. Conexeu Sciences' average media sentiment score of 0.92 beat Sanuwave Health's score of 0.00 indicating that Conexeu Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Conexeu Sciences 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Sanuwave Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to TLSI or SNWV?

In the previous week, Sanuwave Health had 1 more articles in the media than TriSalus Life Sciences. MarketBeat recorded 2 mentions for Sanuwave Health and 1 mentions for TriSalus Life Sciences. TriSalus Life Sciences' average media sentiment score of 1.67 beat Sanuwave Health's score of 0.00 indicating that TriSalus Life Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TriSalus Life Sciences 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Sanuwave Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer SNWV or TMCI?

In the previous week, Sanuwave Health had 1 more articles in the media than Treace Medical Concepts. MarketBeat recorded 2 mentions for Sanuwave Health and 1 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 0.59 beat Sanuwave Health's score of 0.00 indicating that Treace Medical Concepts is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sanuwave Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Treace Medical Concepts 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer SNWV or OBIO?

In the previous week, Sanuwave Health had 1 more articles in the media than Orchestra BioMed. MarketBeat recorded 2 mentions for Sanuwave Health and 1 mentions for Orchestra BioMed. Sanuwave Health's average media sentiment score of 0.00 equaled Orchestra BioMed'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sanuwave Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Orchestra BioMed 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Sanuwave Health (SNWV) Competitors

$10.63 0.00 (0.00%)

Closing price 07/2/2026 04:00 PM Eastern

Extended Trading

$10.58 -0.05 (-0.47%)

As of 07/2/2026 07:23 PM Eastern

Compare

SNWV vs. CNXU, TLSI, TMCI, OBIO, and PROF

Should you buy Sanuwave Health stock or one of its competitors? MarketBeat compares Sanuwave Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Sanuwave Health include Conexeu Sciences (CNXU), TriSalus Life Sciences (TLSI), Treace Medical Concepts (TMCI), Orchestra BioMed (OBIO), and Profound Medical (PROF). These companies are all part of the "medical equipment" industry.

How does Sanuwave Health compare to Conexeu Sciences?

Conexeu Sciences (NASDAQ:CNXU) and Sanuwave Health (NASDAQ:SNWV) are both small-cap medical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment and risk.

Sanuwave Health has a net margin of 35.96% compared to Conexeu Sciences' net margin of 0.00%. Conexeu Sciences' return on equity of 0.00% beat Sanuwave Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conexeu Sciences	N/A	N/A	N/A
Sanuwave Health	35.96%	-450.56%	44.87%

Conexeu Sciences presently has a consensus target price of $20.00, suggesting a potential upside of 84.16%. Sanuwave Health has a consensus target price of $51.00, suggesting a potential upside of 379.77%. Given Sanuwave Health's higher possible upside, analysts plainly believe Sanuwave Health is more favorable than Conexeu Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conexeu Sciences	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

In the previous week, Conexeu Sciences had 11 more articles in the media than Sanuwave Health. MarketBeat recorded 13 mentions for Conexeu Sciences and 2 mentions for Sanuwave Health. Conexeu Sciences' average media sentiment score of 0.92 beat Sanuwave Health's score of 0.00 indicating that Conexeu Sciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conexeu Sciences	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Sanuwave Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

42.5% of Sanuwave Health shares are held by institutional investors. 14.4% of Sanuwave Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Sanuwave Health has higher revenue and earnings than Conexeu Sciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conexeu Sciences	N/A	N/A	N/A	N/A	N/A
Sanuwave Health	$44.05M	2.08	$11.81M	$0.33	32.21

Summary

Sanuwave Health beats Conexeu Sciences on 7 of the 10 factors compared between the two stocks.

How does Sanuwave Health compare to TriSalus Life Sciences?

TriSalus Life Sciences (NASDAQ:TLSI) and Sanuwave Health (NASDAQ:SNWV) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability, media sentiment and analyst recommendations.

TriSalus Life Sciences presently has a consensus price target of $7.50, suggesting a potential upside of 59.91%. Sanuwave Health has a consensus price target of $51.00, suggesting a potential upside of 379.77%. Given Sanuwave Health's stronger consensus rating and higher possible upside, analysts plainly believe Sanuwave Health is more favorable than TriSalus Life Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TriSalus Life Sciences	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Sanuwave Health has lower revenue, but higher earnings than TriSalus Life Sciences. TriSalus Life Sciences is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TriSalus Life Sciences	$45.15M	6.38	-$39.23M	-$1.41	N/A
Sanuwave Health	$44.05M	2.08	$11.81M	$0.33	32.21

Sanuwave Health has a net margin of 35.96% compared to TriSalus Life Sciences' net margin of -60.85%. TriSalus Life Sciences' return on equity of 0.00% beat Sanuwave Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TriSalus Life Sciences	-60.85%	N/A	-69.91%
Sanuwave Health	35.96%	-450.56%	44.87%

TriSalus Life Sciences has a beta of 0.43, indicating that its share price is 57% less volatile than the broader market. Comparatively, Sanuwave Health has a beta of 1.42, indicating that its share price is 42% more volatile than the broader market.

2.6% of TriSalus Life Sciences shares are owned by institutional investors. Comparatively, 42.5% of Sanuwave Health shares are owned by institutional investors. 16.3% of TriSalus Life Sciences shares are owned by company insiders. Comparatively, 14.4% of Sanuwave Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Sanuwave Health had 1 more articles in the media than TriSalus Life Sciences. MarketBeat recorded 2 mentions for Sanuwave Health and 1 mentions for TriSalus Life Sciences. TriSalus Life Sciences' average media sentiment score of 1.67 beat Sanuwave Health's score of 0.00 indicating that TriSalus Life Sciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TriSalus Life Sciences	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Sanuwave Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Sanuwave Health beats TriSalus Life Sciences on 11 of the 17 factors compared between the two stocks.

How does Sanuwave Health compare to Treace Medical Concepts?

Sanuwave Health (NASDAQ:SNWV) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.

Sanuwave Health has higher earnings, but lower revenue than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanuwave Health	$44.05M	2.08	$11.81M	$0.33	32.21
Treace Medical Concepts	$212.69M	1.28	-$59M	-$0.97	N/A

Sanuwave Health has a beta of 1.42, indicating that its share price is 42% more volatile than the broader market. Comparatively, Treace Medical Concepts has a beta of 1.37, indicating that its share price is 37% more volatile than the broader market.

In the previous week, Sanuwave Health had 1 more articles in the media than Treace Medical Concepts. MarketBeat recorded 2 mentions for Sanuwave Health and 1 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 0.59 beat Sanuwave Health's score of 0.00 indicating that Treace Medical Concepts is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sanuwave Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Treace Medical Concepts	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

42.5% of Sanuwave Health shares are held by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are held by institutional investors. 14.4% of Sanuwave Health shares are held by insiders. Comparatively, 23.4% of Treace Medical Concepts shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Sanuwave Health presently has a consensus price target of $51.00, indicating a potential upside of 379.77%. Treace Medical Concepts has a consensus price target of $4.77, indicating a potential upside of 13.30%. Given Sanuwave Health's stronger consensus rating and higher probable upside, research analysts plainly believe Sanuwave Health is more favorable than Treace Medical Concepts.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86

Sanuwave Health has a net margin of 35.96% compared to Treace Medical Concepts' net margin of -29.44%. Treace Medical Concepts' return on equity of -67.04% beat Sanuwave Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sanuwave Health	35.96%	-450.56%	44.87%
Treace Medical Concepts	-29.44%	-67.04%	-30.28%

Summary

Sanuwave Health beats Treace Medical Concepts on 11 of the 16 factors compared between the two stocks.

How does Sanuwave Health compare to Orchestra BioMed?

Sanuwave Health (NASDAQ:SNWV) and Orchestra BioMed (NASDAQ:OBIO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, analyst recommendations, dividends, institutional ownership and risk.

42.5% of Sanuwave Health shares are owned by institutional investors. Comparatively, 53.2% of Orchestra BioMed shares are owned by institutional investors. 14.4% of Sanuwave Health shares are owned by insiders. Comparatively, 7.5% of Orchestra BioMed shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Sanuwave Health has a net margin of 35.96% compared to Orchestra BioMed's net margin of -166.96%. Orchestra BioMed's return on equity of -157.46% beat Sanuwave Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sanuwave Health	35.96%	-450.56%	44.87%
Orchestra BioMed	-166.96%	-157.46%	-60.18%

Sanuwave Health has higher revenue and earnings than Orchestra BioMed. Orchestra BioMed is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanuwave Health	$44.05M	2.08	$11.81M	$0.33	32.21
Orchestra BioMed	$33.48M	7.49	-$52.70M	-$0.97	N/A

Sanuwave Health has a beta of 1.42, suggesting that its share price is 42% more volatile than the broader market. Comparatively, Orchestra BioMed has a beta of 0.49, suggesting that its share price is 51% less volatile than the broader market.

In the previous week, Sanuwave Health had 1 more articles in the media than Orchestra BioMed. MarketBeat recorded 2 mentions for Sanuwave Health and 1 mentions for Orchestra BioMed. Sanuwave Health's average media sentiment score of 0.00 equaled Orchestra BioMed'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sanuwave Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Orchestra BioMed	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Sanuwave Health currently has a consensus target price of $51.00, indicating a potential upside of 379.77%. Orchestra BioMed has a consensus target price of $13.60, indicating a potential upside of 224.58%. Given Sanuwave Health's higher possible upside, analysts clearly believe Sanuwave Health is more favorable than Orchestra BioMed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Orchestra BioMed	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Summary

Sanuwave Health beats Orchestra BioMed on 11 of the 16 factors compared between the two stocks.

How does Sanuwave Health compare to Profound Medical?

Sanuwave Health (NASDAQ:SNWV) and Profound Medical (NASDAQ:PROF) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability.

42.5% of Sanuwave Health shares are held by institutional investors. Comparatively, 47.9% of Profound Medical shares are held by institutional investors. 14.4% of Sanuwave Health shares are held by insiders. Comparatively, 1.5% of Profound Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Sanuwave Health has a net margin of 35.96% compared to Profound Medical's net margin of -206.76%. Profound Medical's return on equity of -78.88% beat Sanuwave Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sanuwave Health	35.96%	-450.56%	44.87%
Profound Medical	-206.76%	-78.88%	-64.06%

Sanuwave Health has a beta of 1.42, meaning that its stock price is 42% more volatile than the broader market. Comparatively, Profound Medical has a beta of 0.73, meaning that its stock price is 27% less volatile than the broader market.

Sanuwave Health currently has a consensus price target of $51.00, suggesting a potential upside of 379.77%. Profound Medical has a consensus price target of $12.00, suggesting a potential upside of 76.21%. Given Sanuwave Health's stronger consensus rating and higher possible upside, analysts plainly believe Sanuwave Health is more favorable than Profound Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Profound Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Sanuwave Health has higher revenue and earnings than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanuwave Health	$44.05M	2.08	$11.81M	$0.33	32.21
Profound Medical	$16.10M	15.37	-$42.57M	-$1.24	N/A

In the previous week, Sanuwave Health had 2 more articles in the media than Profound Medical. MarketBeat recorded 2 mentions for Sanuwave Health and 0 mentions for Profound Medical. Sanuwave Health's average media sentiment score of 0.00 equaled Profound Medical'saverage media sentiment score.

Company	Overall Sentiment
Sanuwave Health	Neutral
Profound Medical	Neutral

Summary

Sanuwave Health beats Profound Medical on 12 of the 15 factors compared between the two stocks.

Get Sanuwave Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNWV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SNWV vs. The Competition

Export

Metric	Sanuwave Health	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$91.41M	$8.69B	$7.16B	$12.48B
Dividend Yield	N/A	2.45%	2.66%	6.52%
P/E Ratio	32.21	16.55	28.02	24.70
Price / Sales	2.08	6.06	540.37	99.49
Price / Cash	6.26	18.11	49.26	57.09
Price / Book	55.95	3.53	10.96	6.46
Net Income	$11.81M	$226.25M	$3.57B	$337.01M
7 Day Performance	23.46%	1.50%	2.12%	1.69%
1 Month Performance	-27.98%	-0.23%	5.25%	3.81%
1 Year Performance	-66.41%	-0.49%	33.29%	23.90%

Sanuwave Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SNWV Sanuwave Health	1.7028 of 5 stars	$10.63 flat	$51.00 +379.8%	-66.4%	$91.41M	$44.05M	32.21	40
CNXU Conexeu Sciences	4.654 of 5 stars	$10.96 +7.2%	$20.00 +82.5%	N/A	$293.27M	N/A	N/A	4	Analyst Revision
TLSI TriSalus Life Sciences	3.5319 of 5 stars	$4.73 +8.2%	$7.50 +58.6%	-8.4%	$290.50M	$45.15M	N/A	106	Positive News Gap Down High Trading Volume
TMCI Treace Medical Concepts	2.1858 of 5 stars	$4.46 +0.2%	$4.77 +7.0%	-30.4%	$289.33M	$212.69M	N/A	250	Positive News High Trading Volume
OBIO Orchestra BioMed	3.6176 of 5 stars	$4.24 +8.7%	$13.60 +220.8%	+44.7%	$253.90M	$33.48M	N/A	4	Gap Up High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SNWV) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sanuwave Health (SNWV) Competitors

SNWV vs. CNXU, TLSI, TMCI, OBIO, and PROF

How does Sanuwave Health compare to Conexeu Sciences?

Summary

How does Sanuwave Health compare to TriSalus Life Sciences?

Summary

How does Sanuwave Health compare to Treace Medical Concepts?

Summary

How does Sanuwave Health compare to Orchestra BioMed?

Summary

How does Sanuwave Health compare to Profound Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SNWV vs. The Competition

Sanuwave Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sanuwave Health (SNWV) Competitors

SNWV vs. CNXU, TLSI, TMCI, OBIO, and PROF

How does Sanuwave Health compare to Conexeu Sciences?

Is CNXU or SNWV more profitable?

Do analysts rate CNXU or SNWV?

Does the media refer more to CNXU or SNWV?

Do institutionals & insiders hold more shares of CNXU or SNWV?

Which has higher earnings and valuation, CNXU or SNWV?

Summary

How does Sanuwave Health compare to TriSalus Life Sciences?

Do analysts prefer TLSI or SNWV?

Which has higher valuation & earnings, TLSI or SNWV?

Is TLSI or SNWV more profitable?

Which has more risk & volatility, TLSI or SNWV?

Do institutionals and insiders have more ownership in TLSI or SNWV?

Does the media refer more to TLSI or SNWV?

Summary

How does Sanuwave Health compare to Treace Medical Concepts?

Which has stronger earnings & valuation, SNWV or TMCI?

Which has more volatility & risk, SNWV or TMCI?

Does the media prefer SNWV or TMCI?

Do institutionals and insiders have more ownership in SNWV or TMCI?

Do analysts prefer SNWV or TMCI?

Is SNWV or TMCI more profitable?

Summary

How does Sanuwave Health compare to Orchestra BioMed?

Do insiders & institutionals believe in SNWV or OBIO?

Is SNWV or OBIO more profitable?

Which has better valuation and earnings, SNWV or OBIO?

Which has more risk and volatility, SNWV or OBIO?

Does the media prefer SNWV or OBIO?

Do analysts rate SNWV or OBIO?

Summary

How does Sanuwave Health compare to Profound Medical?

Do institutionals & insiders hold more shares of SNWV or PROF?

Is SNWV or PROF more profitable?

Which has more risk and volatility, SNWV or PROF?

Do analysts prefer SNWV or PROF?

Which has higher valuation & earnings, SNWV or PROF?

Does the media refer more to SNWV or PROF?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SNWV vs. The Competition

Sanuwave Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools